PRNewswire01.09.20
Zimmer Biomet Holdings Inc. has announced that Keri P. Mattox has been appointed to the newly created position of senior vice president, Investor Relations and chief communications officer.
Mattox joins Zimmer Biomet from W2O Group, an international healthcare-focused marketing and communications firm, where she served as global lead, Integrated Corporate Communications where she was responsible for strategically shaping and expanding the firm's global corporate communications, investor relations, crisis communications, board engagement, and corporate social responsibility/foundation capabilities and offering.
"Keri brings deep expertise and a history of successfully driving effective investor relations, communications, and corporate social responsibility programs," said Suky Upadhyay, CFO of Zimmer Biomet. "Her proven track record of integrating investor relations and communications strategies will be critical as we continue to focus on transforming our business."
Mattox has more than two decades’ experience in investor relations and communications across healthcare distribution, pharmaceuticals, biotech, and medical devices. In her new role at Zimmer Biomet, she is responsible for strategically integrating, aligning, and driving investor relations, communications and philanthropy functions and activities.
Coleman Lannum will be retiring from his position of senior vice president, Investor Relations, but will work closely with Mattox during a transition period.
Mattox joins Zimmer Biomet from W2O Group, an international healthcare-focused marketing and communications firm, where she served as global lead, Integrated Corporate Communications where she was responsible for strategically shaping and expanding the firm's global corporate communications, investor relations, crisis communications, board engagement, and corporate social responsibility/foundation capabilities and offering.
"Keri brings deep expertise and a history of successfully driving effective investor relations, communications, and corporate social responsibility programs," said Suky Upadhyay, CFO of Zimmer Biomet. "Her proven track record of integrating investor relations and communications strategies will be critical as we continue to focus on transforming our business."
Mattox has more than two decades’ experience in investor relations and communications across healthcare distribution, pharmaceuticals, biotech, and medical devices. In her new role at Zimmer Biomet, she is responsible for strategically integrating, aligning, and driving investor relations, communications and philanthropy functions and activities.
Coleman Lannum will be retiring from his position of senior vice president, Investor Relations, but will work closely with Mattox during a transition period.